Vétoquinol S.A., a veterinary pharmaceutical laboratory, designs, develops, and sells veterinary drugs and non-medicinal products serving both the companion animals and livestock, and bred for human food markets in Europe, the Americas, and the Asia Pacific region. It offers pain management, anti-infective, cardiology-nephrology, care and hygiene, antiparasiticides, behavior, internal medicine, and reproduction related products for dogs, cats, cattle, and pigs. The company offers its prdoucts under Tolfedine CS, Tolfine, Cimalgex, Flexadin, Caniviton, Diurizone, Marbocyl, Forcyl, Ceftiocyl, Clavaseptin, Clindaseptin, Cefaseptin, Kefloril, Aurizon, Oridermyl, Longamox, Pen-Histra-Strep, Doxicor, Amoxinsol, Aluspray, Linspec, Permacyl, UpCard, Prilium, Ipakitine/Epakitine, Azodyl, Rubenal, Flevox, Dolpac, Zylkene, and Zentonil brands. The company was founded in 1933 and is headquartered in Lure, France. Vétoquinol S.A. is a subsidiary of Soparfin SCA.
Lure, FR
Size (employees)
2,084 (est)+3%
Vetoquinol was founded in 1933 and is headquartered in Lure, FR

Vetoquinol Office Locations

Vetoquinol has an office in Lure
Lure, FR (HQ)
34 Rue du Chêne Sainte-Anne

Vetoquinol Data and Metrics

Vetoquinol Financial Metrics


Market capitalization (24-Jul-2017)

563.1 m

Closing share price (24-Jul-2017)

Vetoquinol's current market capitalization is €563.1 m.

Vetoquinol Market Value History

Traffic Overview of Vetoquinol

Vetoquinol Online and Social Media Presence

Vetoquinol Company Life and Culture

You may also be interested in